<div class="container">

<table style="width: 100%;"><tr>
<td>optimal_3arm_binary</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Find optimal design parameters
</h2>

<h3>Description</h3>

<p>Find the optimal parameters used in the <code>get_oc_3arm_binary()</code> function
</p>


<h3>Usage</h3>

<pre><code class="language-R">optimal_3arm_binary(p0, p1, p2, p3, alpha = 0.1, beta = 0.2, tot_sample)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>p0</code></td>
<td>

<p>the response rate of historical data
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p1</code></td>
<td>

<p>the response rate of arm 1
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p2</code></td>
<td>

<p>the response rate of arm 2
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p3</code></td>
<td>

<p>the response rate of arm 3
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>

<p>the type I error to be controlled. The default value is alpha = 0.1
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>beta</code></td>
<td>

<p>the type II error to be controlled. The default value is beta = 0.2
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>tot_sample</code></td>
<td>

<p>the required sample size for each arm from function <code>sample_size_3arm_binary()</code>
</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p><code>optimal_3arm_binary()</code> returns: (1) alpha: type I error (2) beta: typeII error (3) r1: the maximum number of successes in stage 1 which will terminate trial (4) n1: the number of subjects in stage 1 (5) r2: the maximum number of successes in stage 2 not to warrant further investigation (6) n: the total number of subjects (stage 1 + stage 2) (7) ESS: the expected sample size for each arm (8) PS:the probability of early stopping
</p>


<h3>Author(s)</h3>

<p>Chia-Wei Hsu, Zongheng Cai, Haitao Pan
</p>


<h3>References</h3>

<p>Cai, Z., Pan, H., Wu, J., Hsu, C.W. (2024). Uncontrolled Randomized Screening Selection Design for Pediatric Oncology Trials. Accepted in Book Chapter of "Master Protocol Clinical Trial for Efficient Evidence Generation"
</p>
<p>Wu, J., Pan, H., &amp; Hsu, C. W. (2022). Two-stage screened selection designs for randomized phase II trials
with time-to-event endpoints. Biometrical Journal, 64(7), 1207-1218
</p>
<p>Yap, C., Pettitt, A. &amp; Billingham, L. Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol 13, 87 (2013)
</p>


<h3>Examples</h3>

<pre><code class="language-R">optimal_3arm_binary(p0 = 0.2, p1 = 0.415, p2 = 0.515, p3 = 0.615,
                    alpha = 0.1, beta = 0.2, tot_sample = 82)
</code></pre>


</div>